PharmaCyte Biotech Inc (PMCB)
2.41
-0.03
(-1.23%)
USD |
NASDAQ |
Mar 28, 16:00
2.41
0.00 (0.00%)
After-Hours: 17:28
PharmaCyte Biotech Market Cap: 20.40M for March 28, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
March 27, 2024 | 20.65M |
March 26, 2024 | 20.65M |
March 25, 2024 | 20.99M |
March 22, 2024 | 20.65M |
March 21, 2024 | 20.40M |
March 20, 2024 | 20.15M |
March 19, 2024 | 18.11M |
March 18, 2024 | 17.01M |
March 15, 2024 | 16.51M |
March 14, 2024 | 17.38M |
March 13, 2024 | 16.87M |
March 12, 2024 | 16.79M |
March 11, 2024 | 17.13M |
March 08, 2024 | 17.55M |
March 07, 2024 | 17.47M |
March 06, 2024 | 17.30M |
March 05, 2024 | 17.30M |
March 04, 2024 | 17.47M |
March 01, 2024 | 17.72M |
February 29, 2024 | 17.89M |
February 28, 2024 | 17.89M |
February 27, 2024 | 17.21M |
February 26, 2024 | 17.72M |
February 23, 2024 | 17.55M |
February 22, 2024 | 17.55M |
Date | Value |
---|---|
February 21, 2024 | 17.55M |
February 20, 2024 | 17.55M |
February 16, 2024 | 17.64M |
February 15, 2024 | 17.81M |
February 14, 2024 | 17.98M |
February 13, 2024 | 17.47M |
February 12, 2024 | 18.49M |
February 09, 2024 | 19.09M |
February 08, 2024 | 18.49M |
February 07, 2024 | 18.87M |
February 06, 2024 | 18.49M |
February 05, 2024 | 18.49M |
February 02, 2024 | 19.00M |
February 01, 2024 | 18.87M |
January 31, 2024 | 18.66M |
January 30, 2024 | 19.39M |
January 29, 2024 | 19.30M |
January 26, 2024 | 18.87M |
January 25, 2024 | 19.47M |
January 24, 2024 | 18.87M |
January 23, 2024 | 19.04M |
January 22, 2024 | 18.78M |
January 19, 2024 | 19.99M |
January 18, 2024 | 19.73M |
January 17, 2024 | 18.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
4.610M
Minimum
Aug 11 2021
80.04M
Maximum
Jan 31 2020
41.51M
Average
45.58M
Median
Market Cap Benchmarks
CEL-SCI Corp | 102.56M |
AIM ImmunoTech Inc | 23.34M |
IGC Pharma Inc | 26.22M |
NovaBay Pharmaceuticals Inc | 0.6830M |
Protalix BioTherapeutics Inc | 92.41M |
Market Cap Related Metrics
PS Ratio | 722.06 |
Price to Book Value | 0.6502 |
Price | 2.41 |
Earnings Yield | -49.79% |